Amid reports of a surge in respiratory illnesses in China, the Virus Research and Diagnostic Laboratories (VRDL) network under the Indian Council of Medical Research (ICMR) has been asked to test all samples of severe acute respiratory infection (SARI), with a particular focus on samples from children, the Government told Parliament on Friday.

Further, a list of priority viral and bacterial agents (including mycoplasma pneumoniae), for which the samples need to be tested, has been shared with the VRDL network, Minister of State for Health S P Singh Baghel said in a written reply to a question in the Lok Sabha.

“While WHO, in the context of surge in respiratory illness in China, has not recommended any trade/travel restrictions, the health ministry continues to maintain a close watch over the evolving situation in China, as well as globally,” Baghel said.

He said the World Health Organisation (WHO), in statements issued on November 22 and 23, reported an increase in the incidence of Influenza-like Illness (ILI) in northern China that has been witnessed since October.

It has been attributed to a rise in the circulation of known pathogens (including influenza, mycoplasma pneumoniae, respiratory syncytial virus (RSV) and SARS-CoV-2) by Chinese authorities, the minister added.

The WHO has also reported clusters of undiagnosed pneumonia among children in northern China.

According to the global body, Chinese authorities have not reported detecting any unusual or novel pathogens or unusual clinical presentations, but a general increase in respiratory illnesses due to multiple known pathogens, Baghel said.

The health ministry, in an advisory issued on November 25, requested all states and Union territories to review their public health and hospital preparedness and response capacities, including a review of the requisite human resource, hospital beds, testing capacities, availability of medical counter-measures and adequate provisioning of infection-control practices at health facilities.